Current Issue

Application of Quality Risk Management to Process Validation

Robert Dream, Managing Director, HDR Company LLC

A Holistic Phase Appropriate Strategy for HCP-Limits and HCP Characterization

Dr. Markus Haindl, Global Head Gene Therapy Technical Research & Development, Roche Di...

Strategies for Extractable and Leachable Risk Assessment of Polymeric Single Use Systems U...

Ping Wang, Director, Johnson & Johnson

Use of Non-Contact Raman Spectroscopy to Derive Reaction Kinetics

Richard Hart, Senior Director – Head of Automation and Data Science (Previously Asso...

Amsphere A3

JSR Life Sciences



Headline News

Zura Bio discontinues tibulizumab development in hidradenitis suppurativa after Phase II miss


Taltz and Zepbound combination maintains improved psoriatic arthritis outcomes at one year


Pasritamig combination delivers 73% PSA response rate in advanced prostate cancer Phase I study


Read All Headlines

Upcoming Webinars

View All Upcoming Webinars

Past Webinars

Accelerating the development of regenerative therapies: Large scale expansion of human mesenchymal stem cells

Presented by Jon Rowley, Ph.D. & Mark Szczypka, Ph.D.
28th March 2017


Case Study: CMC Biologics Explores the Potential of Continuous Multi-Column Chromatography

Presented by Michelle Najera, PhD, CMC Biologics, Downstream Process Development Scientist and Lynne Frick, Director of Sales, Continuous Bioprocessing, Pall Life Sciences
06th February 2017


Mechanistic Modelling in Early Stage Chromatography Process Development for Improving Process Efficiency and Productivity

Presented by Yuyi Shen, Associate Director, Process Development and Manufacturing at Bolt Therapeutics and Nick Whitelock, Business Development Manager at GoSilico GmbH
19th April 2021


View All Past Webinars

Featured Companies

 

View All Companies

© 2026 biopharma-asia.com. All rights reserved. Privacy Policy

Biopharma Asia